Publications by authors named "M A G Sprangers"

Purpose: Our objectives were to identify characteristics of response shift studies using patient-reported outcomes (PROMs) that explain variability in (1) the detection and (2) the magnitude of response shift effects.

Methods: We conducted a systematic review of quantitative studies published before June 2023. First, two-level multivariable logistic regression models (effect- and sample-levels) were used to explain variability in the probability of finding a response shift effect.

View Article and Find Full Text PDF

Prior research has shown that patients with early Barrett's neoplasia treated endoscopically report at least the same level of fear for cancer recurrence as patients treated surgically for a more advanced disease stage. The aim of this qualitative study was to gain insight into the reasons why endoscopically treated patients fear or not fear cancer recurrence. Patients treated endoscopically for T1 esophageal adenocarcinoma participated in a semi-structured interview.

View Article and Find Full Text PDF

Introduction: Gastroesophageal cancer patients' information needs remain understudied, despite their complex treatment trajectories.

Methods: This study examined the (i) information needs of patients with or without postoperative complications, (ii) information needs of male and female patients, and (iii) the association between information needs and health-related quality of life (HR-QoL) following gastroesophageal cancer surgery. Patients completed the EORTC-QLQ-INFO25, QLQ-C30, and QLQ-OG25 questionnaires before and after curative surgery.

View Article and Find Full Text PDF
Article Synopsis
  • The article presents a correction to the findings previously published in DOI: 10.1371/journal.pone.0234543.
  • It highlights specific errors or inaccuracies that were identified in the original study.
  • The authors provide updated data or clarifications to ensure the integrity and accuracy of the research.
View Article and Find Full Text PDF

Background: Chemotherapy for various stages of gastroesophageal cancer (GEC) is often neurotoxic. Chemotherapy-induced peripheral neuropathy (CIPN) impairs health-related quality of life (HRQoL). This study investigates the incidence and severity of CIPN and its association with HRQoL in patients with GEC.

View Article and Find Full Text PDF